Glancy Prongay & Murray LLP Announces Investigation on Behalf of Evolent Health, Inc. Investors (EVH)
Evolent Health, Inc Class A (EVH)
Last evolent health, inc class a earnings: 2/25 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.evolenthealth.com
Company Research
Source: Business Wire
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Evolent Health, Inc. (“Evolent” or the “Company”) (NYSE: EVH) investors concerning the Company and its officers’ possible violations of federal securities laws.If you are a shareholder who suffered a loss, click here to participate.If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.On May 29, 2019, Evolent announced that it had agreed to purchase a controlling interest in University Health Care, Inc., d/b/a/ Passport Health Plan, despite prior statements that acquiring health plans was not part of the Company’s strategic focus.On this news, Evolent’s share price fell $4.14 per share, nearly 30%, to clo
Show less
Read more
Impact Snapshot
Event Time:
EVH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVH alerts
High impacting Evolent Health, Inc Class A news events
Weekly update
A roundup of the hottest topics
EVH
News
- Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1PR Newswire
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.MarketBeat
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.MarketBeat
- Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]Yahoo! Finance
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.MarketBeat
EVH
Earnings
- 11/7/24 - Miss
EVH
Sec Filings
- 12/11/24 - Form 8-K
- 11/12/24 - Form SC
- 11/8/24 - Form 10-Q
- EVH's page on the SEC website